Sp1117
PRO: SPLEEN PRESERVATION SHOULD BE ROUTINELY PERFORMED FOR NON-PDAC MINIMALLY INVASIVE DISTAL PANCREATECTOMY
Date
May 21, 2024
Presenter
Univ. Texas MD Anderson Cancer Center
Tracks
Related Products
CLASSIFICATION OF POST-PANCREATECTOMY READMISSIONS WITH OPPORTUNITIES FOR TARGETED MITIGATION STRATEGIES
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
VALIDATION AND RECALIBRATION OF RISK-STRATIFIED PANCREATODUODENECTOMY DRAIN FLUID AMYLASE REMOVAL CRITERIA
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
PROSPECTIVE EVALUATION OF PROVIDER COMPLIANCE WITH RISK-STRATIFIED PANCREATECTOMY CLINICAL PATHWAYS
BACKGROUND: Risk-stratified pancreatectomy clinical pathways (RSPCP) are associated with reduced length of stay (LOS) and major complications…
VALIDATION AND RECALIBRATION OF RISK-STRATIFIED PANCREATODUODENECTOMY DRAIN FLUID AMYLASE REMOVAL CRITERIA
Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
